NovoCure Limited
NVCR
$12.43
$0.524.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 911.53M | 929.13M | 959.87M | 959.90M | 951.19M |
| Total Receivables | 129.05M | 118.55M | 77.55M | 92.50M | 97.56M |
| Inventory | 40.21M | 39.47M | 35.09M | 39.10M | 40.44M |
| Prepaid Expenses | -- | -- | 7.32M | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.51M | 2.15M | 26.74M | 3.78M | 3.65M |
| Total Current Assets | 1.08B | 1.09B | 1.11B | 1.10B | 1.09B |
|
|
|||||
| Total Current Assets | 1.08B | 1.09B | 1.11B | 1.10B | 1.09B |
| Net Property, Plant & Equipment | 147.01M | 145.02M | 119.59M | 114.49M | 107.27M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 15.56M | 14.48M | 14.62M | 12.22M | 12.06M |
| Total Assets | 1.25B | 1.25B | 1.24B | 1.22B | 1.21B |
|
|
|||||
| Total Accounts Payable | 103.68M | 95.09M | 105.09M | 91.32M | 90.17M |
| Total Accrued Expenses | -- | -- | 70.98M | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 559.79M | 558.97M | 566.07M | 557.33M | -- |
| Total Finance Division Other Current Liabilities | 86.17M | 89.25M | 14.24M | 86.35M | 79.01M |
| Total Other Current Liabilities | 86.17M | 89.25M | 14.24M | 86.35M | 79.01M |
| Total Current Liabilities | 749.63M | 743.31M | 756.38M | 735.00M | 169.18M |
|
|
|||||
| Total Current Liabilities | 749.63M | 743.31M | 756.38M | 735.00M | 169.18M |
| Long-Term Debt | 97.61M | 97.45M | 97.30M | 97.15M | 653.47M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 42.85M | 40.31M | 19.97M | 21.14M | 21.73M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.34M | 5.79M | 6.96M | 7.91M | 6.04M |
| Total Liabilities | 896.43M | 886.85M | 880.61M | 861.21M | 850.42M |
|
|
|||||
| Common Stock & APIC | 1.58B | 1.55B | 1.52B | 1.45B | 1.42B |
| Retained Earnings | -1.23B | -1.19B | -1.15B | -1.09B | -1.06B |
| Treasury Stock & Other | -5.11M | -4.20M | -5.50M | -5.38M | -3.52M |
| Total Common Equity | 349.44M | 361.96M | 360.18M | 360.78M | 361.75M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 349.44M | 361.96M | 360.18M | 360.78M | 361.75M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 349.44M | 361.96M | 360.18M | 360.78M | 361.75M |
|
|
|||||